T-cell checkpoint modulators and closed tumor microenvironment modifiers (Jounce Therapeutics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameT-cell checkpoint modulators and closed tumor microenvironment modifiers (Jounce Therapeutics)
Drug Alias Namecancer immunotherapies (Jounce Therapeutics)
ClassificationSmall molecules
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJounce Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJounce Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A